Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization

Hepatology

Volumn 37, Issue 2, 2003, Pages 452-460

  Jiao, Xuanmao ^a   Wang, Richard Y H ^a   Feng, Zhiming ^a   Alter, Harvey J ^a   Shih, James Wai Kuo ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DIOLEOYL SN GLYCEROL 3 ETHYLPHOSPHOCHOLINE; AMMONIUM DERIVATIVE; BROMINE DERIVATIVE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DIOLEOYLPHOSPHATIDYLCHOLINE; DNA VACCINE; HEPATITIS C VACCINE; HEPATITIS C VIRUS NONSTRUCTURAL PROTEIN 3; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIPOSOME; PROPANE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TH1 CELL; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

EID: 0037311229     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50051     Document Type: Article

References (52)

1. Cohen J. The scientific challenge of hepatitis C. Science 1999;285:26-30.
2. Stratton KR, Durch JS, Lawrence RS, Hepatitis C. Vaccines for the 21st century. Washington, DC: National Academy Press, 2000.
3. Poynard T, Marcellin P, Lee SS, Niederan C, Minuk G, Bain V, Heathcote J, et al. Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-1432.
4. MaHutchison JG, Gorden SC, Schiff ER, Lee WM, Rustgi VK, Goodman ZD, Ling MH, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New Engl J Med 1998;339:1485-1492.
5. Rehemann B, Chisary FV. Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 2000;242:299-325.
6. Diepolder HM, Zachoval RM, Hoffmann RM, Wierenga EA, Santantonia T, Jung MC, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
7. Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Guo GC. Detection of type-2 like T-helper cells in hepatitis C virus infection: implication for hepatitis C chronicity. HEPATOLOGY 1997;25:449-458.
8. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997;71:6011-6019.
9. Chen Z, Wang RY-H, Alter HJ, Shih JW-K. Genetic immunization of mice with plasmids containing hepatitis C virus cote protein-encoding DNA. Vaccine Res 1995;4:135-144.
10. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trepo C, Inchauspe G. DNA-based immunization with chimeric vector for the induction of immune response against the hepatitis C virus nucleocapsid. J Virol 1995;69:5798-5805.
11. Hu G-J, Wang RY-H, Han D-S, Alter HJ, Shih JW-K. Characterization of the humoral and cellular immune response against hepatitis C virus core induced by DNA-based immunization. Vaccine 1999;17:3160-3170.
12. Vadalin O, Tanaka E, Spengler U, Trepo C, Inchauspe G. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune response to DNA vaccination. DNA Cell Biol 1999;18:611-621.
13. Tedeshi V, Akatsuka T, Shih JW-K, Ballegay M, Feinstone SM. A specific antibody response to HCV E2 elicited in mice by intramuscle inoculation of plasmid DNA containing coding sequence for E2. HEPATOLOGY 1997;25:459-462.
14. Saito T, Sherman GJ, Kurokohchi K, Guo Z-P, Donets M, Yu M-YW, Berzofsky JA, et al. Plasmid DNA-based immunization for hepatitis C virus structural proteins, immune response in mice. Gastroenterology 1997;112:1321-1320.
15. Nakino I, Maertens G, Major ME, Virvitski L, Dubuisson J, Fournillier A, De Martynoff G, et al. Immunization with plasmid DNA encoding hepatitis C virus envelop E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol 1997;71:7101-7109.
16. Forns X, Emerson SU, Tobin GJ, Mushahwar IK, Purcell RH, Bukh J. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelop E2 protein expressed intracellularly and on the cell surface. Vaccine 1999;17:1992-2002.
17. Cho JH, Lee SW, Sung YC. Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophagecolony stimulating factor gene in intramuscular DNA immunization. Vaccine 1999;17:1136-1144.
18. Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. J Infect Dis 2000;182:18-27.
19. Zucchelli S, Capone S, Fattori E, Folgori A, Di Marco A, Casimiro D, Simon AJ, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000;74:11598-11607.
20. Lazdina U, Hultgren C, Frelin L, Chen M, Lodin K, Weiland O, Leroux-Roels G, et al. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. J Gen Virol 2001;82:1299-1308.
21. Lewis PJ, Babiuk LA, DNA vaccines: a review. Adv Virus Res 1999;54:129-188.
22. Gregoriadis G. Genetic vaccines: strategies for optimisation. Pharm Res 1998;15:661-670.
23. Davis HL, Whalen RG, Demeneix B. Direct gene transfer in skeletal muscle in vivo: factors influencing efficiency of transfer and stability of expression. Hum Gene Ther 1993;4:151-156.
24. + T cells following particle mediated DNA vaccination: implications for the study of immunomodulation. Vaccine 2001;19:1678-1687.
25. Zucchelli S, Capone S, Fattori E, Folgori A, Marco AD, Casimiro D, Simon AJ, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000;74:11598-11607.
26. Mittal SK, Aggarwal N, Sailaja G, van Olphen A, HogenEsch H, North A, Hays J, et al. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine 2001;19:253-263.
27. Dietrich G, Gentschev I, Hess J, Ulmers JB, Kaufmann SHE, Goebel W. Delivery of DNA vaccine by attenuated intracellular bacteria. Immunol Today 1999;20:251-253.
28. Gregoriadis G, Saffie R, de Souza JB. Liposome-mediated DNA vaccination. FEBS Lett 1997;402:107-110.
29. Dow SW, Fradkin LG, Liggitt DH, Willson AP, Heath TD, Potter TA. Lipid-DNA complex induce potent activation ofinnate immune responses and antitumor activity when administered intravenously. J Immunol 1999;163:1552-1561.
30. Lanuti M, Rudginsky S, Force SD, Lambright ES, Siders WM, Chang MY, Amin KM, et al. Cationic lipid: bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Res 2000;60:2955-2963.
31. Perrie Y, Frederick PM, Gregoriadis G. Liposome mediated DNA vaccination: the effect of vesicle composition. Vaccine 2001;19:3301-3310.
32. Zhou W-Z, Kaneda Y, Huang SKS, Morishita R, Hoon DSB. Protective immunization against melonoma by gp-100 DNA-HVJ-liposome vaccine. Gene Ther 1999;6:1768-1773.
33. Cusi MG, Zurbriggen R, Valassina M, Bianchi S, Durrer P, Valensin PE, Donity M, et al. Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity. Virology 2000;277:111-118.
34. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-410.
35. Whitmore M, Li S, Huang L, LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 1999;6:1867-1875.
36. Brunel F, Darbouret A, Ronco J. Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine. Vaccine 1999;17:2192-2203.
37. Kirby C, Gregoriadis G. Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 1984;11:979-984.
38. Vold MJ, Vold RD. Colloid chemistry: The science of large molecules, small particles, and surfaces. New York: Reinhold Publishing Corp., 1964.
39. Encke J, zu Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998;161:4917-4923.
40. Gorden EJ, Bhat R, Liu Q, Wang Y-F, Tackney C, Prince AM. Immune responses to hepatitis C virus structural and nonstructral proteins induced by plasmid DNA immunizations. J Infect Dis 2000;181:42-50.
41. Bennet DE, O'Brien DF. Photoactivated enhancement of liposome fusion. Biochemistry 1995;34:3102-3113.
42. Leikins S, Parsegian VA, Rau DC, Hydration forces. Annu Rev Phys Chem 1993;44:369-395.
43. Kourilsky P, Truffa-Bachi P. Cytokine fields and the polarization of the immune response. Trends Immunol 2001;22:502-509.
44. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity 1996;5:303-310.
45. Krieg AM. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol 1996;4:73-76.
46. Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996;157:2116-2122.
47. Klinman DM, Yi A, Beaucage SJ, Conover J, Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12, and interferon-γ Proc Natl Acad Sci U S A 1996;93:2879-2883.
48. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 1997;84:185-193.
49. Yi A, Klinman DM, Martin TL, Matson S, Krieg AM. Rapid immune activation by CpG motifs in bacterial DNA. J Immunol 1996;157:5394-5402.
50. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-1845.
51. Friend DS, Papahadjopoulos D, Debs RJ. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta 1996;1278:41.
52. McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman R, Thurston G, et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes. Am J Physiol 1997;273:H387-H404.